High Risk Biochemical Relapse and the Timing of Androgen Deprivation Therapy

Medicine and Dentistry

• Androgen Deprivation Therapy 100%
• Biochemical Recurrence 100%
• Androgen 100%
• Prostate Specific Antigen 87%
• Prostate Cancer 50%
• Recurrent Disease 37%
• Metastatic Carcinoma 25%
• Clinical Trial 12%
• Disease Course 12%
• Radiation Therapy 12%

Keyphrases

• High Risk 100%
• Androgen Deprivation Therapy 100%
• Biochemical Relapse 100%
• Prostate-specific Antigen 30%
• Nonmetastatic Prostate Cancer 30%
• Prostate-specific Antigen Doubling Time 30%
• Metastatic Disease 20%
• Recurrent Disease 20%
• High-risk Features 20%
• Clinical Course 10%
• Radiation Therapy 10%
• Retrospective Data 10%
• Clinical Trial Data 10%
• Retrospective Analysis 10%
• High-grade Prostate Cancer 10%
• Prostate-specific Antigen Recurrence 10%
• Large Amount of Data 10%